Brief: Pixium Vision Welcomes Judgment By Paris Commercial Court Against Second Sight Medical Products
Dec 28 (Reuters) - Pixium Vision SA ALPIX.PA :
* COURT ORDERS SECOND SIGHT MEDICAL PRODUCTS TO PAY PIXIUM
VISION
AN ADDITIONAL EUR 1.58 MILLION IN COSTS AND DAMAGES
* COURT FINDS SECOND SIGHT MEDICAL PRODUCTS BREACHED 2021
CONTRACTUAL OBLIGATIONS TO PIXIUM VISION
* PARIS COMMERCIAL COURT ALSO DECIDED THAT THIS TOTAL AMOUNT
OF
EUR 2,530,000 IS TO BE REDUCED BY $1,000,000 THAT PIXIUM VISION
HAD ALREADY RECEIVED FROM SECOND SIGHT MEDICAL PRODUCTS IN APRIL
2021
* PIXIUM VISION IS PLEASED WITH DECISION OF PARIS COMMERCIAL
COURT, WHICH IS SUBJECT TO APPEAL
Source text for Eikon: ID:nGNE9zGFcb
Further company coverage: ALPIX.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7785110;))
Recent news on Pixium Vision SA
See all newsBrief: Pixium Vision SA Says Paris Commercial Court Postponed Decision On Takeover Offer Filed On Nov 20, 2023
Brief: Pixium Vision: opening of judicial liquidation proceedings has been postponed to later date
Brief: Pixium Vision Announces Decision About Adoption Of Sale Plan, Opening Of Judicial Liquidation Proceedings Planned For Jan 16, 2024
Brief: Pixium Vision SA Announces Conversion Of Safeguard Proceedings Into Receivership
Brief: Pixium Vision Announces Tender Process For Purpose Of Finding Buyers To Acquire Company's Business Will Be Published Tomorrow